학술논문
A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials
Document Type
Article
Source
In: Expert Review of Cardiovascular Therapy . (Expert Review of Cardiovascular Therapy, 2024, 22(1-3):131-139)
Subject
Language
English
ISSN
17448344
14779072
14779072